课题基金 / 基金详情

Selective disruption of hippocampal dentate granule cells in autism: impact of PT

Selective disruption of hippocampal dentate granule cells in autism: impact of PT
自闭症患者海马齿状颗粒细胞的选择性破坏:PT 的影响
批准号:
8411855
负责人:
Steve C Danzer
金额:
$1.46万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-04-30

项目摘要

项目成果

Steve C Danzer的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在儿童的发育过程中,大部分脑细胞在出生前就产生了。然而,有一类脑细胞是在婴儿时期大量生成的。这发生在一个叫做海马体的大脑区域。这些细胞对记忆、认知和语言的正常发育很重要,自闭症儿童中存在这些细胞的破坏。这些细胞的破坏也可能导致自闭症儿童癫痫的流行。虽然这些细胞对自闭症的关键特征负责是有道理的,但患有这种疾病的儿童在大脑的许多其他部位也表现出变化。不幸的是,我们对哪些变化是重要的理解有限,减缓了这一领域的进展。因此,在目前的提议中,我们将研究消除已知与自闭症有关的基因对这些晚期生成细胞的影响。这些研究将揭示是否有选择地破坏这些细胞可以重现自闭症的特征。证明这些细胞在自闭症(或癫痫等相关疾病)的发展中起着重要作用,将为开发保护这些脆弱细胞的新疗法提供令人信服的理由。此外,由于这些细胞在发育过程中出生很晚,实际上是在童年和成年期间产生的,因此有可能防止自闭症诊断后出生的细胞被破坏,从而使大脑自然恢复。我们希望这些研究将使我们更接近于开发新的更有效的自闭症治疗方法。公共卫生相关性:拟议的研究试图通过确定选择性破坏晚期生成的神经元(特别是海马齿状颗粒细胞)是否有助于自闭症的关键特征来更好地阐明自闭症的原因。这将通过一种新的转基因小鼠组合来实现,这种组合可以选择性地从这些晚期产生的神经元中消除与自闭症有关的基因。值得注意的是,尽管在大多数情况下自闭症的近端原因仍有待确定,但这些神经元的生成较晚(在胚胎后期和婴儿期)可能使它们特别容易受到新生儿所面临的各种伤害(例如感染)。该提案还将研究颗粒细胞在癫痫发展中的作用,癫痫是最常与自闭症相关的疾病。
英文摘要
DESCRIPTION (provided by applicant): During the development of a child, most brain cells are generated before birth. There is one group of brain cells, however, that are generated in large numbers in infancy. This occurs in a brain region called the hippocampus. These cells are important for the normal development of memory, cognition and language, and disruption of these cells is present in children with autism. Disruption of these cells may also contribute to the prevalence of epilepsy in children with autism. Although it makes sense that these cells are responsible for key features of autism, children with the disease exhibit changes in many other parts of the brain as well. Our limited understanding of which changes are important, unfortunately, has slowed progress in the field. In the present proposal, therefore, we will examine the impact of eliminating a gene known to be involved in autism on these late-generated cells. These studies will reveal whether selectively disrupting these cells can reproduce features of autism. Demonstrating that these cells play an important role in the development of autism (or associated conditions like epilepsy), will provide a compelling rationale to develop new therapies to protect these vulnerable cells. In addition, since these cells are born so late in development, and are actually produced through childhood and into adulthood, it may be possible to prevent the disruption of cells born after a diagnosis of autism and thus allow the brain to naturally restore itself. It is our hope that these studies will move us closer to developing new and more effective treatments for autism. PUBLIC HEALTH RELEVANCE: The proposed studies seek to better elucidate the causes of autism by determining whether selective disruption of late-generated neurons - specifically hippocampal dentate granule cells - contributes to key features of autism. This will be achieved using a novel combination of transgenic mice to selectively eliminate a gene implicated in autism from these late-generated neurons. Significantly, although the proximal cause of autism remains to be determined in most cases, the late generation of these neurons (in the late embryonic period and in infancy) may make them uniquely vulnerable to a variety of insults faced by the newborn child (e.g. infection). The proposal will also examine the role of granule cells in the development of epilepsy, the condition most commonly associated with autism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-epileptogenic role of mTOR activation among hippocampal interneurons
Anti-epileptogenic role of mTOR activation among hippocampal interneurons
mTOR regulation of aberrant neuronal integration and epileptogenesis in epilepsy
Identification and reversal of primary and secondary epileptogenic changes
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: